Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 52 Records) |
Query Trace: Splenomegaly and JAK2[original query] |
---|
Incidence and risk factors for myelofibrotic transformation among 272 Chinese patients with JAK2-mutated polycythemia vera. American journal of hematology 2015 Sep . Bai Jie, Ai Limei, Zhang Lei, Yang Fengchun, Zhou Yuan, Xue Yanpi |
Prognostic value of CALR vs. JAK2V617F mutations on splenomegaly, leukemic transformation, thrombosis, and overall survival in patients with primary fibrosis: a meta-analysis. Annals of hematology 2016 Jul . Pei Yu-Qing, Wu Yue, Wang Fei, Cui W |
Disease characteristics and outcomes in younger adults with primary and secondary myelofibrosis. British journal of haematology 2016 Jun . Beauverd Yan, Alimam Samah, McLornan Donal P, Radia Deepti H, Harrison Claire |
Determination of prognosis of Philadelphia chromosome-negative myeloproliferative neoplasms with a simple clinical examination: Retrospective analysis of 71 patients in a single institution. Molecular and clinical oncology 2016 Jan 4 (1): 51-57. Ito Shinichi, Tsutsumi Yutaka, Ohigashi Hiroyuki, Shiratori Souichi, Teshima Takano |
Bone marrow microvessel density and plasma angiogenic factors in myeloproliferative neoplasms: clinicopathological and molecular correlations. Annals of hematology 2016 Dec . Lekovic Danijela, Gotic Mirjana, Skoda Radek, Beleslin-Cokic Bojana, Milic Natasa, Mitrovic-Ajtic Olivera, Nienhold Ronny, Sefer Dijana, Suboticki Tijana, Buac Marijana, Markovic Dragana, Diklic Milos, Cokic Vladan |
Primary myelofibrosis: Older age and high JAK2V617F allele burden are associated with elevated plasma high-sensitivity C-reactive protein levels and a phenotype of progressive disease. Leukemia research 2017 Jun 60 18-23. Barosi Giovanni, Massa Margherita, Campanelli Rita, Fois Gabriela, Catarsi Paolo, Viarengo Gianluca, Villani Laura, Poletto Valentina, Bosoni Tiziana, Magrini Umberto, Gale Robert P, Rosti Vittor |
The prognostic relevance of serum lactate dehydrogenase and mild bone marrow reticulin fibrosis in essential thrombocythemia. American journal of hematology 2017 Feb . Mudireddy Mythri, Barraco Daniela, Hanson Curtis A, Pardanani Animesh, Gangat Naseema, Tefferi Ayal |
Estimation of diagnosis and prognosis in ET by assessment of CALR and JAK2 mutations and laboratory findings: a meta-analysis. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2017 Feb . Saki N, Shirzad R, Rahim F, Saki Malehi |
Bone marrow fibrosis in chronic myelomonocytic leukemia is associated with increased megakaryopoiesis, splenomegaly and with a shorter median time to disease progression. Oncotarget 2017 Nov 8 (61): 103274-103282. Petrova-Drus Kseniya, Chiu April, Margolskee Elizabeth, Barouk-Fox Sharon, Geyer Julia, Dogan Ahmet, Orazi Attil |
Chronic Myelomonocytic Leukemia With Fibrosis Is a Distinct Disease Subset With Myeloproliferative Features and Frequent JAK2 p.V617F Mutations. The American journal of surgical pathology 2018 Mar . Gur Hatice D, Loghavi Sanam, Garcia-Manero Guillermo, Routbort Mark, Kanagal-Shamanna Rashmi, Quesada Andres, Khogeer Haitham, Pierce Sherry, Medeiros L Jeffrey, Kantarjian Hagop, Khoury Joseph |
Effect of CALR and JAK2 mutations on the clinical and hematological phenotypes of the disease in patients with myelofibrosis - long-term experience from a single center. Neoplasma 2018 65 (2): 296-303. Palova M, Szotkowski T, Hlusi A, Indrak K, Navratilova J, Divoka M, Papajik |
Mutational subtypes of JAK2 and CALR correlate with different clinical features in Japanese patients with myeloproliferative neoplasms. International journal of hematology 2018 Feb . Misawa Kyohei, Yasuda Hajime, Araki Marito, Ochiai Tomonori, Morishita Soji, Shirane Shuichi, Edahiro Yoko, Gotoh Akihiko, Ohsaka Akimichi, Komatsu Nor |
Quantitative assessment of JAK2 V617F and CALR mutations in Philadelphia negative myeloproliferative neoplasms. Leukemia research 2018 Jan 65 42-48. Gángó Ambrus, Mózes Réka, Boha Zsófia, Kajtár Béla, Timár Botond, Király Péter Attila, Kiss Richárd, Fésüs Viktória, Nagy Noémi, Demeter Judit, Körösmezey Gábor, Borbényi Zita, Marton Imelda, Sz?ke Anita, Masszi Tamás, Farkas Péter, Várkonyi Judit, Plander Márk, Pósfai Éva, Egyed Miklós, Pál Katalin, Radványi Gáspár, Hamed Aryan, Csomor Judit, Matolcsy András, Alpár Donát, Bödör Csa |
Prevalence of MPL (W515K/L) Mutations in Patients with Negative-JAK2 (V617F) Myeloproliferative Neoplasm in North-East of Iran. Iranian journal of pathology 2018 13 (4): 397-402. Shams Seyyede Fatemeh, Ayatollahi Hossein, Sadeghian Mohammad Hadi, Afzalaghaee Monavar, Shakeri Sepideh, Yazdandoust Ehsan, Sheikhi Maryam, Amini Nafiseh, Bakhshi Samane, Bahrami Afsa |
WT1 gene is overexpressed in myeloproliferative neoplasms, especially in myelofibrosis. Blood cells, molecules & diseases 2019 1 75 35-40. Cottin Laurane, Riou Jérémie, Boyer Françoise, Bouvier Anne, Zannetti Alain, Blouet Anaïse, Truchan-Graczyk Matgorzata, Jouanneau-Courville Rébecca, Beucher Annaëlle, Ribourtout Bénédicte, Orvain Corentin, Hunault-Berger Mathilde, Blanchet Odile, Ugo Valérie, Luque Paz Dami |
Genetic polymorphisms and expression of NLRP3 inflammasome-related genes are associated with Philadelphia chromosome-negative myeloproliferative neoplasms. Human immunology 2020 9 81 (10-11): 606-613. Zhou Ying, Yan Shuxin, Liu Na, He Na, Zhang Amin, Meng Sibo, Ji Chunyan, Ma Daoxin, Ye Jingji |
Polycythemia Vera Presenting With Normal Hemoglobin and Hematocrit: A Rare Variant. Cureus 2020 7 12 (6): e8404. Erdinc Burak, Ramachandran Preethi, Boris Avezbakiy |
No Differences in Outcomes Between JAK2 V617F-Positive Patients with Variant Allele Fraction < 2% Versus 2-10%: A 6-Year Province-wide Retrospective Analysis. Clinical lymphoma, myeloma & leukemia 2020 5 20 (9): e569-e578. Limvorapitak Wasithep, Parker Jeremy, Hughesman Curtis, McNeil Kelly, Foltz Lynda, Karsan A |
Disease-Specific Derangement of Circulating Endocannabinoids and N-Acylethanolamines in Myeloproliferative Neoplasms. International journal of molecular sciences 2020 5 21 (9): . Forte Dorian, Fanelli Flaminia, Mezzullo Marco, Barone Martina, Corradi Giulia, Auteri Giuseppe, Bartoletti Daniela, Martello Marina, Ottaviani Emanuela, Terragna Carolina, Curti Antonio, Pagotto Uberto, Palandri Francesca, Cavo Michele, Catani Luc |
Low prevalence of JAK2 V617F mutation in patients with thrombosis and normal blood counts: a retrospective impact study. Journal of thrombosis and thrombolysis 2020 4 50 (4): 995-1003. Levraut Michaël, Legros Laurence, Drappier Charles, Béné Marie C, Queyrel Viviane, Raynaud Sophie, Martis Nih |
Bone marrow megakaryocytic activation predicts fibrotic evolution of Philadelphia-negative myeloproliferative neoplasms. Haematologica 2020 11 . Schino Mattia, Fiorentino Vincenzo, Rossi Elena, Betti Silvia, Di Cecca Monica, Ranucci Valentina, Chiusolo Patrizia, Martini Maurizio, De Stefano Valerio, Larocca Luigi Mar |
[Clinical Characteristics of Patients with JAK2 Gene Mutation Myeloproliferative Neoplasms]. Zhongguo shi yan xue ye xue za zhi 2021 10 29 (5): 1533-1539. Li Yu-Jin, Zhu Shi-Rong, Liu Wei-Yi, Ming Jing, Wang Zi-Qing, Zhang Shan-Shan, Hu Xiao-M |
Janus Kinase-2 Mutation Associated Portal Vein Thrombosis Complicating Liver Cirrhosis and Hepatocellular Carcinoma. Asian Pacific journal of cancer prevention : APJCP 2021 1 22 (1): 267-275. Rabie Hatem, Othman Warda, Elsabaawy Dalia M, Elshemy Eman E, Abdelmageed Neamat, Khalaf Fatma A, Bedair Hanan |
MPN-500 The Characteristics of Patients With Unprovoked Venous Thrombotic Events With JAK2 GGCC (46/1) Haplotype Treated in Tertiary Care Center in Saudi Arabia. Clinical lymphoma, myeloma & leukemia 2022 9 22 Suppl 2 S340-S341. King Shatha Alana |
Coexistence of Chronic Myelomonocytic Leukemia and Ulcerative Colitis With Rapid Progression to Acute Myelomonocytic Leukemia: A Case Report. Cureus 2022 3 14 (2): e22422. Pelkey Lauren J, Graham David M, Zakem Michael H, Muza-Moons Michelle |
Triple-Negativity Identifies a Subgroup of Patients with Better Overall Survival in Essential Thrombocythemia. Hematology reports 2022 Aug 14 (3): 265-269. Santoro Marco, Accurso Vincenzo, Mancuso Salvatrice, Napolitano Mariasanta, Mattana Marta, Vajana Giorgia, Russello Federica, Siragusa Serg |
Allelic burden of Janus kinase 2 in a 6-month course of therapy for myeloproliferative neoplasms. Molecular biology reports 2023 5 . It?r ?irino?lu Demiriz, Mehmet Hanifi Kazanci, Esra Menfaatli, Davoud Jafari-Gharabaghlou, Nosratollah Zargha |
Genetic and Clinical Characteristics of Patients with Philadelphia-Negative Myeloproliferative Neoplasm Carrying Concurrent Mutations in JAK2V617F, CALR, and MPL. Technology in cancer research & treatment 2023 2 22 15330338231154092. Wang Yan, Ran Fei, Lin Jin, Zhang Jing, Ma D |
The Impact of JAK2 V617F, CALR, and MPL Mutations as Molecular Diagnostic Markers of Myeloproliferative Neoplasms in Kurdish Patients. A Single-center Experience. Cellular and molecular biology (Noisy-le-Grand, France) 2023 2 68 (8): 202-209. Basim Najm Maysam, Jalal Sana Dlawar, Getta Hisham Ar |
Molecular landscape of the JAK2 gene in chronic myeloproliferative neoplasm patients from the state of Amazonas, Brazil. Biomedical reports 2023 11 19 (6): 98. Dania G Torres, Emanuela V Barbosa Alves, Miliane Araújo de Sousa, Wanessa H Laranjeira, Jhemerson Paes, Erycka Alves, Deborah Canté, Allyson G Costa, Adriana Malheiro, Rosângela Abreu, Leny Nascimento, Nelson A Fraiji, George A V Silva, Lucivana P de Souza Mourão, Andréa M Tarra |
- Page last reviewed:Feb 1, 2024
- Page last updated:Mar 25, 2024
- Content source: